GPX4 and breast cancer: Upon targeted internalization into BC cells, these nanoparticles released a substantial amount of ROS, which not only induced apoptosis by collapsing the mitochondrial membrane potential but also activated the ferroptosis pathway by depleting reduced GSH and downregulating GPX4, thereby achieving an anti-tumor effect [104].